Oncology Dominant As Japan Maintains Approvals Pace
Several Global Firsts In Annual Tally
Despite the emergence of the coronavirus pandemic at the end of the period, Japan’s regulatory authorities maintained an annual pace of new drug approvals on a par with the previous year, with expedited programs helping several drugs to market.
